Literature DB >> 7055383

A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models.

C L Day, R A Lew, M C Mihm, A J Sober, M N Harris, A W Kopf, T B Fitzpatrick, T J Harrist, F M Golomb, A Postel, P Hennessey, S L Gumport, J W Raker, R A Malt, A B Cosimi, W C Wood, D F Roses, F Gorstein, D Rigel, R J Friedman, M M Mintzis, R W Grier.   

Abstract

Fourteen prognostic factors were examined in 79 patients with clinical Stage I melanoma greater than or equal to 3.65 mm in thickness. All nine patients with melanoma of the hands or feet died of melanoma. A Cox proportional hazards (multivariate) analysis of the remaining 70 patients showed that a combination of the following four variables best predicted bony or visceral metastases: 1) a nearly absent or minimal lymphocyte response at the base of the tumor, 2) histologic type other than superficial spreading melanoma, 3) location on the trunk, and 4) positive nodes or no initial node dissection. Ulceration and/or ulceration width were not useful in predicting outcome either singly or in combination with other variables. Patients with negative lymph nodes and primary tumors of the trunk, hands, and feet did not do better than patients with positive nodes at those sites. Conversely, non of 16 patients with negative lymph nodes and extremity melanomas (excluding the hands and feet) or head and neck melanomas developed visceral or bony metastases (i.e., five-year disease-free survival rate 100%).

Entities:  

Mesh:

Year:  1982        PMID: 7055383      PMCID: PMC1352402          DOI: 10.1097/00000658-198201001-00007

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  20 in total

1.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

Authors:  E A GEHAN
Journal:  Biometrika       Date:  1965-06       Impact factor: 2.445

2.  Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

Authors:  A Breslow
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

3.  Tumor thickness as a guide to surgical management of clinical stage I melanoma patients.

Authors:  C M Balch; T M Murad; S J Soong; A L Ingalls; P C Richards; W A Maddox
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

4.  The natural break points for primary-tumor thickness in clinical Stage I melanoma.

Authors:  C L Day; R A Lew; M C Mihm; M N Harris; A W Kopf; A J Sober; T B Fitzpatrick
Journal:  N Engl J Med       Date:  1981-11-05       Impact factor: 91.245

5.  Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat.

Authors:  C L Day; T J Harrist; F Gorstein; A J Sober; R A Lew; R J Friedman; B S Pasternack; A W Kopf; T B Fitzpatrick; M C Mihm
Journal:  Ann Surg       Date:  1981-07       Impact factor: 12.969

6.  Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis.

Authors:  C L Day; M C Mihm; R A Lew; M N Harris; A W Kopf; T B Fitzpatrick; T J Harrist; F M Golomb; A Postel; P Hennessey; S L Gumport; J W Raker; R A Malt; A B Cosimi; W C Wood; D F Roses; F Gorstein; D Rigel; R J Friedman; M M Mintzis; A J Sober
Journal:  Ann Surg       Date:  1982-01       Impact factor: 12.969

7.  The regressing thin malignant melanoma: a distinctive lesion with metastatic potential.

Authors:  M A Gromet; W L Epstein; M S Blois
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

8.  A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma.

Authors:  C M Balch; S J Soong; T M Murad; A L Ingalls; W A Maddox
Journal:  Surgery       Date:  1979-08       Impact factor: 3.982

9.  Malignant melanoma patients with positive nodes and relatively good prognoses: microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes.

Authors:  C L Day; A J Sober; R A Lew; M C Mihm; T B Fitzpatrick; A W Kopf; M N Harris; S L Gumport; J W Raker; R A Malt; F M Golomb; A B Cosimi; W C Wood; P Casson; S Lopransi; F Gorstein; A Postel
Journal:  Cancer       Date:  1981-03-01       Impact factor: 6.860

10.  Stage I melanoma of the limbs. Immediate versus delayed node dissection.

Authors:  U Veronesi; J Adamus; D C Bandiera; I O Brennhovd; E Caceres; N Cascinelli; F Claudio; R L Ikonopisov; V V Javorskj; S Kirov; A Kulakowski; J Lacour; F Lejeune; Z Mechl; A Morabito; I Rodé; S Sergeev; E van Slooten; K Szczygiel; N N Trapeznikov; R I Wagner
Journal:  Tumori       Date:  1980-06-30
View more
  11 in total

1.  One-year follow-up of panic disorder. Outcome and prognostic factors.

Authors:  W Maier; R Buller
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988

2.  The incidental malignant melanoma.

Authors:  R R Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-29

3.  The incidental malignant melanoma.

Authors:  R H Griffiths; J C Briggs
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-19

4.  Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes.

Authors:  M Hishii; J T Kurnick; T Ramirez-Montagut; F Pandolfi
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

5.  Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma.

Authors:  S M Kheir; S D Bines; J H Vonroenn; S J Soong; M M Urist; J S Coon
Journal:  Ann Surg       Date:  1988-04       Impact factor: 12.969

6.  The highly attenuated vaccinia virus strain modified virus Ankara induces apoptosis in melanoma cells and allows bystander dendritic cells to generate a potent anti-tumoral immunity.

Authors:  S Greiner; J Y Humrich; P Thuman; B Sauter; G Schuler; L Jenne
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

7.  The extent of primary melanoma excision. A re-evaluation--how wide is wide?

Authors:  D R Aitken; K Clausen; J P Klein; A G James
Journal:  Ann Surg       Date:  1983-11       Impact factor: 12.969

8.  Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis.

Authors:  C L Day; M C Mihm; R A Lew; M N Harris; A W Kopf; T B Fitzpatrick; T J Harrist; F M Golomb; A Postel; P Hennessey; S L Gumport; J W Raker; R A Malt; A B Cosimi; W C Wood; D F Roses; F Gorstein; D Rigel; R J Friedman; M M Mintzis; A J Sober
Journal:  Ann Surg       Date:  1982-01       Impact factor: 12.969

Review 9.  Reflections on the Histopathology of Tumor-Infiltrating Lymphocytes in Melanoma and the Host Immune Response.

Authors:  Martin C Mihm; James J Mulé
Journal:  Cancer Immunol Res       Date:  2015-08       Impact factor: 11.151

10.  The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients.

Authors:  A C Häffner; C Garbe; G Burg; P Büttner; C E Orfanos; G Rassner
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.